{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T19:20:54Z","timestamp":1770751254461,"version":"3.50.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T00:00:00Z","timestamp":1768348800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T00:00:00Z","timestamp":1770681600000},"content-version":"vor","delay-in-days":27,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Guangzhou Medical Key Subject Construction Project","award":["2025-2027"],"award-info":[{"award-number":["2025-2027"]}]},{"name":"Huadu District People's Hospital of Guangzhou Internal Research Fund Project","award":["2024C11"],"award-info":[{"award-number":["2024C11"]}]},{"name":"Huadu District Basic and Applied Basic Research Joint Funding Project (District-Hospital Collaboration), Guangzhou","award":["23HDQYLH07"],"award-info":[{"award-number":["23HDQYLH07"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"DOI":"10.1186\/s12882-025-04724-w","type":"journal-article","created":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T15:07:57Z","timestamp":1768403277000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Probable neuropsychiatric toxicity induced by dihydrocodeine in a peritoneal dialysis patient: a case report and literature review"],"prefix":"10.1186","volume":"27","author":[{"given":"Zihan","family":"Lei","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiaqi","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunfang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen","family":"Ling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,14]]},"reference":[{"issue":"6470","key":"4724_CR1","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1136\/bmj.290.6470.740","volume":"290","author":"JN Barnes","year":"1985","unstructured":"Barnes JN, Williams AJ, Tomson MJ, et al. Dihydrocodeine in renal failure: further evidence for an important role of the kidney in the handling of opioid drugs. Br Med J (Clin Res Ed). 1985;290(6470):740\u20132. https:\/\/doi.org\/10.1136\/bmj.290.6470.740.","journal-title":"Br Med J (Clin Res Ed)"},{"key":"4724_CR2","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1093\/ndt\/14.4.903","volume":"14","author":"C Pauli-Magnus","year":"1999","unstructured":"Pauli-Magnus C, Hofmann U, Mikus G, et al. Pharmacokinetics of morphine and its glucuronides following intravenous administration of morphine in patients undergoing continuous ambulatory peritoneal Dialysis. Nephrol Dial Transpl. 1999;14:903\u20139. https:\/\/doi.org\/10.1093\/ndt\/14.4.903.","journal-title":"Nephrol Dial Transpl"},{"key":"4724_CR3","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1093\/bja\/70.5.511","volume":"70","author":"MH Hanna","year":"1993","unstructured":"Hanna MH, D\u2019Costa F, Peat SJ, et al. Morphine-6-glucuronide disposition in renal impairment. Br J Anaesth. 1993;70:511\u20134. https:\/\/doi.org\/10.1093\/bja\/70.5.511.","journal-title":"Br J Anaesth"},{"key":"4724_CR4","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1177\/0897190019853992","volume":"33","author":"NA Slater","year":"2020","unstructured":"Slater NA, Todd AM, Trimmier M, et al. Morphine use in renal failure: A case report of Single-Dose morphine toxicity in a patient requiring peritoneal Dialysis. J Pharm Pract. 2020;33:903\u20136. https:\/\/doi.org\/10.1177\/0897190019853992.","journal-title":"J Pharm Pract"},{"key":"4724_CR5","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/clpt.1981.154","volume":"30","author":"CA Naranjo","year":"1981","unstructured":"Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30:239\u201345. https:\/\/doi.org\/10.1038\/clpt.1981.154.","journal-title":"Clin Pharmacol Ther"},{"key":"4724_CR6","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1007\/s00204-021-03211-z","volume":"96","author":"JY Akakpo","year":"2022","unstructured":"Akakpo JY, Ramachandran A, Curry SC, et al. Comparing N-acetylcysteine and 4-methylpyrazole as antidotes for acetaminophen overdose. Arch Toxicol. 2022;96:453\u201365. https:\/\/doi.org\/10.1007\/s00204-021-03211-z.","journal-title":"Arch Toxicol"},{"key":"4724_CR7","doi-asserted-by":"publisher","DOI":"10.5772\/intechopen.1010151","volume-title":"Poisoning \u2013 New insights","author":"M Elbidairi","year":"2025","unstructured":"Elbidairi M. Paracetamol (acetaminophen) poisoning. Poisoning \u2013 New insights. London: IntechOpen; 2025. https:\/\/doi.org\/10.5772\/intechopen.1010151."},{"key":"4724_CR8","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1097\/00005344-199011000-00024","volume":"251","author":"D Paul","year":"1989","unstructured":"Paul D, Standifer KM, Inturrisi CE, et al. Pharmacological characterization of morphine-6 beta-glucuronide, a very potent morphine metabolite. J Pharmacol Exp Ther. 1989;251:477\u201383. https:\/\/doi.org\/10.1097\/00005344-199011000-00024.","journal-title":"J Pharmacol Exp Ther"},{"key":"4724_CR9","doi-asserted-by":"publisher","first-page":"410","DOI":"10.2165\/00003088-199631060-00002","volume":"31","author":"G Davies","year":"1996","unstructured":"Davies G, Kingswood C, Street M. Pharmacokinetics of opioids in renal dysfunction. Clin Pharmacokinet. 1996;31:410\u201322. https:\/\/doi.org\/10.2165\/00003088-199631060-00002.","journal-title":"Clin Pharmacokinet"},{"key":"4724_CR10","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1002\/med.20035","volume":"25","author":"GJ Kilpatrick","year":"2005","unstructured":"Kilpatrick GJ, Smith TW. Morphine-6-glucuronide: actions and mechanisms. Med Res Rev. 2005;25:521\u201344. https:\/\/doi.org\/10.1002\/med.20035.","journal-title":"Med Res Rev"},{"key":"4724_CR11","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1097\/00000542-199407000-00013","volume":"81","author":"G D\u2019Honneur","year":"1994","unstructured":"D\u2019Honneur G, Gilton A, Sandouk P, et al. Plasma and cerebrospinal fluid concentrations of morphine and morphine glucuronides after oral morphine. The influence of renal failure. Anesthesiology. 1994;81:87\u201393. https:\/\/doi.org\/10.1097\/00000542-199407000-00013.","journal-title":"Anesthesiology"},{"key":"4724_CR12","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.2307\/29512223","volume":"287","author":"N Redfern","year":"1983","unstructured":"Redfern N. Dihydrocodeine overdose treated with Naloxone infusion. Br Med J. 1983;287:1143. https:\/\/doi.org\/10.2307\/29512223.","journal-title":"Br Med J"},{"key":"4724_CR13","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1007\/s00228-009-0759-8","volume":"66","author":"H Molanaei","year":"2010","unstructured":"Molanaei H, Carrero JJ. Olof Heimb\u00fcrger,et al.Influence of the CYP2D6 polymorphism and Hemodialysis on Codeine disposition in patients with end-stage renal disease. Eur J Clin Pharmacol. 2010;66:269\u201373. https:\/\/doi.org\/10.1007\/s00228-009-0759-8.","journal-title":"Eur J Clin Pharmacol"},{"key":"4724_CR14","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1038\/s41401-024-01255-2","volume":"45","author":"RJ Mu","year":"2024","unstructured":"Mu RJ, Liu TL, Liu XD, et al. PBPK-PD model for predicting morphine pharmacokinetics, CNS effects and Naloxone antagonism in humans. Acta Pharmacol Sin. 2024;45:1752\u201364. https:\/\/doi.org\/10.1038\/s41401-024-01255-2.","journal-title":"Acta Pharmacol Sin"},{"key":"4724_CR15","doi-asserted-by":"publisher","first-page":"3856","DOI":"10.1111\/bph.16394","volume":"181","author":"D Budda","year":"2024","unstructured":"Budda D, G\u00fclave B, van Hasselt JGC, et al. Non-linear blood\u2013brain barrier transport and dosing strategies influence receptor occupancy ratios of morphine and its metabolites in pain matrix. Br J Pharmacol. 2024;181:3856\u201368. https:\/\/doi.org\/10.1111\/bph.16394.","journal-title":"Br J Pharmacol"},{"issue":"3","key":"4724_CR16","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1097\/ALN.0000000000004622","volume":"139","author":"M Van Lemmen","year":"2023","unstructured":"Van Lemmen M, Florian J, Li Z, et al. Opioid overdose: limitations in Naloxone reversal of respiratory depression and prevention of cardiac arrest. Anesthesiology. 2023;139(3):342\u201353. https:\/\/doi.org\/10.1097\/ALN.0000000000004622.","journal-title":"Anesthesiology"},{"key":"4724_CR17","doi-asserted-by":"publisher","first-page":"4659","DOI":"10.1038\/s41467-025-59932-7","volume":"16","author":"MA Van Lemmen","year":"2025","unstructured":"Van Lemmen MA, van Velzen M, Sarton EY, et al. A comparison of intramuscular (zimhi) and intranasal Naloxone (narcan) in reversal of fentanyl-induced apnea: a randomized, crossover, open-label trial. Nat Commun. 2025;16:4659. https:\/\/doi.org\/10.1038\/s41467-025-59932-7.","journal-title":"Nat Commun"},{"key":"4724_CR18","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1021\/acsptsci.1c00168","volume":"4","author":"AJ Kassick","year":"2021","unstructured":"Kassick AJ, Wu M, Luengas D, et al. Covalently loaded Naloxone nanoparticles as a Long-Acting medical countermeasure to opioid poisoning. ACS Pharmacol Transl Sci. 2021;4:1654\u201364. https:\/\/doi.org\/10.1021\/acsptsci.1c00168.","journal-title":"ACS Pharmacol Transl Sci"},{"key":"4724_CR19","doi-asserted-by":"publisher","first-page":"000538258","DOI":"10.1159\/000538258","volume":"49","author":"S Liu","year":"2024","unstructured":"Liu S, Sands MB, Kerferd JW, et al. Opioid analgesic use among patients with kidney disease: a systematic review. Kidney Blood Press Res. 2024;49:000538258. https:\/\/doi.org\/10.1159\/000538258.","journal-title":"Kidney Blood Press Res"},{"key":"4724_CR20","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1097\/MNH.0000000000000646","volume":"29","author":"PJ Roy","year":"2020","unstructured":"Roy PJ, Weltman M, Dember LM, et al. Pain management in patients with chronic kidney disease and end-stage kidney disease. Curr Opin Nephrol Hypertens. 2020;29:552\u20139. https:\/\/doi.org\/10.1097\/MNH.0000000000000646.","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"4724_CR21","doi-asserted-by":"publisher","first-page":"523","DOI":"10.2174\/138945010791170879","volume":"11","author":"L Pasquale Niscola","year":"2010","unstructured":"Pasquale Niscola L, Scaramucci G, Vischini, et al. The use of major analgesics in patients with renal dysfunction. Curr Drug Targets. 2010;11:523\u20138. https:\/\/doi.org\/10.2174\/138945010791170879.","journal-title":"Curr Drug Targets"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-025-04724-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-025-04724-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-025-04724-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T11:23:51Z","timestamp":1770722631000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12882-025-04724-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,14]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4724"],"URL":"https:\/\/doi.org\/10.1186\/s12882-025-04724-w","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,14]]},"assertion":[{"value":"23 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study has been performed in accordance with the Declaration of Helsinki and been reviewed by the Ethics Committee of Guangzhou Huadu District People\u2019s Hospital (Approval No. (2025)-0174), and informed consent has been obtained from the patients.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Written informed consent was obtained from the patient for publication of this case report. Following assessment by the Ethics Committee, it was determined that the patient had the capacity to understand and provide informed consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"104"}}